EPZM - Epizyme, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue21,70010,0008,0072,560
Cost of Revenue105,833109,66191,461111,209
Gross Profit-84,133-99,661-83,454-108,649
Operating Expenses
Research Development----
Selling General and Administrative43,97237,18128,37223,900
Non Recurring----
Others----
Total Operating Expenses149,805146,842119,833135,109
Operating Income or Loss-128,105-136,842-111,826-132,549
Income from Continuing Operations
Total Other Income/Expenses Net4,5322,1971,614173
Earnings Before Interest and Taxes-128,105-136,842-111,826-132,549
Interest Expense----
Income Before Tax-123,573-134,645-110,212-132,376
Income Tax Expense57-336--
Minority Interest----
Net Income From Continuing Ops-123,630-134,309-110,212-132,376
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-123,630-134,309-110,212-132,376
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-123,630-134,309-110,212-132,376